| Dr Roger David Polish, MD | |
|
66 Calle Santa Cruz, Instituto San Pablo, Suite 502, Bayamon, PR 00961-7041 | |
| (787) 778-0632 | |
| (787) 778-3720 |
| Full Name | Dr Roger David Polish |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 29 Years |
| Location | 66 Calle Santa Cruz, Bayamon, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528047339 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 0101055566 (Virginia) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | 15803 (Puerto Rico) | Primary |
| Entity Name | Roger Polish, Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083863344 PECOS PAC ID: 7012213572 Enrollment ID: O20160309000837 |
News Archive
Predictive Biosciences today announced that the Company will be presenting results on the development of a real-time multiplexed PCR assay for detection of FGFR3 mutations in urine and tissue at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17 - 19 in Orlando, Florida. Results will also focus on the application of the assay which is currently being used in Predictive's first commercial molecular grading product, the CertNDxTM Molecular Grading Assay.
OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, has announced positive preliminary animal data demonstrating the benefits of combining the company's ImmunoPulse with anti-CTLA4 and anti-PD1 antibodies.
Having a stroke or mini stroke has a much more profound effect on women than men when it comes to their quality of life, according to research published in the August issue of the Journal of Clinical Nursing.
There are many kinds of cancer, but treatments have typically combatted them in one way only: by attempting to destroy the cancerous cells. Surgery aims to remove the entire growth from the body; chemotherapy drugs are toxic to the cancer cells; radiation generates toxic molecules that break up the cancer cells' DNA and proteins, causing their demise.
In the first study of its kind, researchers from the University of Surrey and Princess Alice Hospice investigated the bereavement support provided to children before and after a parent's death.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roger David Polish, MD 66 Calle Santa Cruz, Instituto San Pablo, Suite 502, Bayamon, PR 00961-7041 Ph: (787) 778-0632 | Dr Roger David Polish, MD 66 Calle Santa Cruz, Instituto San Pablo, Suite 502, Bayamon, PR 00961-7041 Ph: (787) 778-0632 |
News Archive
Predictive Biosciences today announced that the Company will be presenting results on the development of a real-time multiplexed PCR assay for detection of FGFR3 mutations in urine and tissue at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17 - 19 in Orlando, Florida. Results will also focus on the application of the assay which is currently being used in Predictive's first commercial molecular grading product, the CertNDxTM Molecular Grading Assay.
OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, has announced positive preliminary animal data demonstrating the benefits of combining the company's ImmunoPulse with anti-CTLA4 and anti-PD1 antibodies.
Having a stroke or mini stroke has a much more profound effect on women than men when it comes to their quality of life, according to research published in the August issue of the Journal of Clinical Nursing.
There are many kinds of cancer, but treatments have typically combatted them in one way only: by attempting to destroy the cancerous cells. Surgery aims to remove the entire growth from the body; chemotherapy drugs are toxic to the cancer cells; radiation generates toxic molecules that break up the cancer cells' DNA and proteins, causing their demise.
In the first study of its kind, researchers from the University of Surrey and Princess Alice Hospice investigated the bereavement support provided to children before and after a parent's death.
› Verified 5 days ago
Jannette Marie Figueroa-velez, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 100 Paseo San Pablo, Edif Dr Arturo Cadilla Vinas Suite 104, Bayamon, PR 00960 Phone: 787-269-2442 | |
Dr. Ana I Rivera De La Vega, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 100 Paseo San Pablo, Edif. Dr. Arturo Cadilla, Suite 201, Bayamon, PR 00961 Phone: 787-778-8774 Fax: 787-269-6190 | |
Boris M Guzman-hernandez, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: Mq10 Plaza 37, Monte Claro, Bayamon, PR 00961 Phone: 787-245-8870 Fax: 787-858-0434 | |
Jose M Rodriguez Castro, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: Edif Metromedical, A- 608, Bayamon, PR 00959 Phone: 787-395-7125 Fax: 787-395-7126 | |
Dalvert H Polanco, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 100 Ave Laurel, Bayamon, PR 00956 Phone: 787-787-5151 | |
Dr. Isabel E Cestero, M. D. Gastroenterology Medicare: Medicare Enrolled Practice Location: Route #2 Km 11.7 Bayamon Medical Plaza, Suite 409-b, Bayamon, PR 00959 Phone: 787-786-0473 Fax: 787-786-9718 | |
Joham Senior Marino, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: Piso 1 Suite 104a, Bayamon Medical Plaza, Bayamon, PR 00960 Phone: 787-798-9522 Fax: 787-798-9500 |